BioSpace News Archive

Aditxt, Inc. announced that it has received confirmation from The Nasdaq Stock Market LLC Hearing Panel that it has regained compliance with minimum stockholders’ equity requirement in Nasdaq Listing Rule 5550, subject to a mandatory panel monitor until December 29, 2024.

Cloud DX Inc. (TSXV: CDX) (OTCQB: CDXFF) (“Cloud DX” or the “Company”), is pleased to announce that, further to the Company’s news release dated December 7, 2023, it has closed its previously announced non-brokered private

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the addition of Terilyn Juarez Monroe as the company’s chief people officer, effective immediately.

Starton Therapeutics Inc. (“Starton” or the “Company”) announced today that it has filed provisional patent applications with the U.S. Patent and Trademark Office (USPTO) for unique and novel approaches to incorporate various active pharmaceutical ingredients (APIs) into transdermal drug delivery systems, where such APIs have typically been difficult to incorporate in a transdermal drug delivery system platform.

Fortrea today announced that Chairman and Chief Executive Officer, Tom Pike and Chief Financial Officer, Jill McConnell will present at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10 at 3:00 pm PST.